Abstract
Aims
Flucloxacillin is a frequently used antibiotic in the treatment of spondylodiscitis. We assessed steady-state concentrations and time above minimal inhibitory concentration (fT > MIC) of flucloxacillin in the intervertebral disc, vertebral cancellous bone, subcutaneous tissue and plasma, after intravenous and oral administration.
Methods
Sixteen pigs were randomized into two groups; Group Peroral (Group PO) and Group Intravenous (Group IV) received 1 g flucloxacillin every 6 h for 24 h orally or intravenously. Microdialysis was used for sampling in the compartments of interest. A flucloxacillin target of 50% fT > MIC was applied for three MIC targets: 0.125, 0.5 and 2.0 μg/mL.
Results
Intravenous administration resulted in significantly longer fT > MIC for all targets. Target attainment was only reached for the low target of 0.125 μg/mL in Group IV in vertebral cancellous bone, subcutaneous tissue, and plasma (intervertebral disc 47%). In Group IV, mean fT > MIC values in the investigated compartments were in the range of 47–67% of the dosing interval for 0.125 μg/mL, 20–35% for 0.5 μg/mL, and 0–15% for 2.0 μg/mL. In Group PO, mean fT > MIC values for 0.125 μg/mL were in the range of 1–33%. No pigs reached a concentration of 0.5 μg/mL in any of the investigated compartments in Group PO.
Conclusion
Administration of 1 g flucloxacillin every 6 h resulted in surprisingly low steady-state fT > MIC after intravenous and oral administration. However, intravenous administration resulted in significantly higher concentrations across compartments compared to oral administration. Sufficient target tissue concentrations for treatment of spondylodiscitis may require a dose increase or alternative dosing regimens.
Similar content being viewed by others
References
Lener S et al (2018) Management of spinal infection: a review of the literature. Acta Neurochir (Wien) 160(3):487–496
Cottle L, Riordan T (2008) Infectious spondylodiscitis. J Infect 56(6):401–412
Gouliouris T, Aliyu SH, Brown NM (2010) Spondylodiscitis: update on diagnosis and management. J Antimicrob Chemother 65(Suppl 3):iii11–iii24
Giordan E et al (2019) Outcomes and risk factors for spontaneous spondylodiscitis: case series and meta-analysis of the literature. J Clin Neurosci 68:179–187
Hopkinson N, Patel K (2016) Clinical features of septic discitis in the UK: a retrospective case ascertainment study and review of management recommendations. Rheumatol Int 36(9):1319–1326
Preiss H, Kriechling P, Montrasio G, Huber T, Janssen I, Moldovan A, Lipsky BA, Uçkay I (2020) Oral flucloxacillin for treating osteomyelitis: a narrative review of clinical practice. J Bone Joint Infect 5(1):16–24
Bue M et al (2018) Vancomycin concentrations in the cervical spine after intravenous administration: results from an experimental pig study. Acta Orthop 89(6):683–688
Hanberg P et al (2016) Pharmacokinetics of single-dose cefuroxime in porcine intervertebral disc and vertebral cancellous bone determined by microdialysis. Spine J 16(3):432–438
Flecknell P (2002) Replacement, reduction and refinement. Altex 19(2):73–78
Bendtsen MAF et al (2021) Flucloxacillin bone and soft tissue concentrations assessed by microdialysis in pigs after intravenous and oral administration. Bone Joint Res 10(1):60–67
Ferrero MMA et al (1993) Plasma and bone concentrations of cefuroxime and flucloxacillin—Oral versus parenteral administration in 20 arthroplasties. Acta Orthop Scand 64(5):525–529
Ferrero MMA et al (1994) Relationship between plasma and bone concentrations of cefuroxime and flucloxacillin. Biopharm Drug Dispos 15(7):599–608
Torkington MS et al (2017) Bone penetration of intravenous flucloxacillin and gentamicin as antibiotic prophylaxis during total hip and knee arthroplasty. Bone Joint J 99(3):358–364
Kho CM et al (2017) A review on microdialysis calibration methods: the theory and current related efforts. Mol Neurobiol 54(5):3506–3527
Hanberg P et al (2019) Single-dose pharmacokinetics of meropenem in porcine cancellous bone determined by microdialysis: an animal study. Bone Joint Res 8(7):313–322
Bue M et al (2018) Bone and subcutaneous adipose tissue pharmacokinetics of vancomycin in total knee replacement patients. Acta Orthop 89(1):95–100
Joukhadar C, Muller M (2005) Microdialysis: current applications in clinical pharmacokinetic studies and its potential role in the future. Clin Pharmacokinet 44(9):895–913
European Committee on Antimicrobial Susceptibility Testing 2020 https://www.eucast.org/mic_distributions_and_ecoffs/ Accessed 14 Apr 2020
Wayne PA (2020) Principles and procedures for the development of epidemiological cutoff values for antifungal susceptibility testing. CLSI supplement M57. Clinical and Laboratory Standards Institute https://clsi.org/media/1670/m57ed1_sample.pdf Accessed 8 Nov 2020
Clinical and Laboratory Institute https://clsi.org Accessed 14 Apr 2020
Ulldemolins M et al (2010) Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics. J Antimicrob Chemother 65(8):1771–1778
Weis S et al (2019) Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect 25(7):818–827
Landersdorfer CB et al (2007) Population pharmacokinetics at two dose levels and pharmacodynamic profiling of flucloxacillin. Antimicrob Agents Chemother 51(9):3290–3297
Bue M et al (2018) Single-dose bone pharmacokinetics of vancomycin in a porcine implant-associated osteomyelitis model. J Orthop Res 36(4):1093–1098
Jensen LK et al (2017) Suppurative inflammation and local tissue destruction reduce the penetration of cefuroxime to infected bone implant cavities. J Comp Pathol 157(4):308–316
Vertebral osteomyelitis and discitis in adults 2020 https://www-uptodate-com.ez.statsbiblioteket.dk:12048/contents/vertebral-osteomyelitis-and-discitis-in-adults?search=Vertebral%20osteomyelitis%20and%20discitis%20in%20adults&source=search_result&selectedTitle=1~114&usage_type=default&display_rank=1#H25 Accessed 9 Nov 2020
Li HK et al (2019) Oral versus intravenous antibiotics for bone and joint infection. N Engl J Med 380(5):425–436
Cyriac JM, James E (2014) Switch over from intravenous to oral therapy: a concise overview. J Pharmacol Pharmacother 5(2):83–87
Sutherland R, Croydon EA, Rolinson GN (1970) Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin. Br Med J 4(5733):455–460
Wallenburg E et al (2021) A meta-analysis of protein binding of flucloxacillin in healthy volunteers and hospitalized patients. Clin Microbiol Infect 28(3):446-e1
Roberts S et al (2006) Histology and pathology of the human intervertebral disc. J Bone Joint Surg Am 88(Suppl 2):10–14
Alini M et al (2008) Are animal models useful for studying human disc disorders/degeneration? Eur Spine J 17(1):2–19
Funding
The authors wish to thank Sofus Carl Emil Friis Foundation, Aase & Ejnar Danielsen’s Foundation, the Augustinus Foundation, Direktør Emil Hertz og hustru Inger Hertz Foundation, and the Novo Nordisk Foundation for supporting this study financially. No competing interests were declared.
Author information
Authors and Affiliations
Contributions
MAFB: Drafted the manuscript. Acquisition, analysis and interpretation of data. PH: Designed the study. Interpretation of data. Critical revision. JS: Acquisition of data. Critical revision. JH: Responsible for chemical analysis of drug levels. Critical revision. KÖ-H: Designed the study. Interpretation of data. Critical revision. MS: Designed the study. Interpretation of data. Critical revision. Supervision of research. Approval of final version to publish. MB: Designed the study. Interpretation of data. Critical revision. Supervision of research. Approval of final version to publish.
Corresponding author
Ethics declarations
Conflict of interest
All authors have no conflicts of interest to declare with relevance to the present article. All authors have no financial or non-financial interest to disclose in relation to the content of this article. All authors have no affiliation with or involvement in any organisation with financial or non-financial interest in the subject or materials discussed in the present article. All authors declare no financial or proprietary interest in any material discussed in this manuscript
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bendtsen, M.A.F., Hanberg, P., Slater, J. et al. Steady-state concentrations of flucloxacillin in porcine vertebral cancellous bone and intervertebral disc following oral and intravenous administration assessed by microdialysis. Eur Spine J 31, 1508–1514 (2022). https://doi.org/10.1007/s00586-022-07208-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00586-022-07208-9